Skip To Main Content
Maria Teresa Bourlon on Muck Rack

Maria Teresa Bourlon

As seen in: Urology Times
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maria Teresa

Contact Maria Teresa, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nivolumab + Cabozantinib Remains Standard of Care in First-Line Treatment for Advanced Renal Cell Carcinoma

|
By Maria Teresa Bourlon
| BestPractice Nordic DK Verified
april 2024 In this MEDtalk, Maria Teresa Bourlon presents the updated efficacy in the intention-to-treat population at 55-month median follow-up on the CheckMate 9ER phase 3 trial. The results show that the combination therapy with nivo+cabo continues to maintain meaningful long-term benefits in efficacy endpoints, such as progression-free survival, overall survival, and overall response rates.
Open in Who Shared Issue with article?

The 10th Annual Symposium on Global Cancer Research: New Models for Global Cancer Research, Training, and Control

|
By Fatou Jallow, Mishka Kohli Cira, Kalina Duncan, Maria Teresa Bourlon
| ascopubs.org
As we enter the third year of the global COVID-19 pandemic and broader social justice movement, long-standing inequities in health are again receiving heightened attention.
Open in Who Shared Issue with article?

The 10th Annual Symposium on Global Cancer Research: New Models for Global Cancer Research, Training, and Control

|
By Fatou Jallow, Maria Teresa Bourlon, Mishka Kohli Cira, Kalina Duncan
| ascopubs.org
DOI: 10.1200/GO.22.00122 JCO Global Oncology 8 no. Supplement_1 (2022) 1-3. Published online May 5, 2022.
Open in Who Shared View Duplicates (2) Issue with article?
See all 3 licensed articles (13 Total)